Science RSS Feeds
In October 2017, astronomers spotted a strange, incredibly fast-moving object hurtling through the solar system. 'Oumuamua—a Hawaiian term roughly translating to “scout” or a “messenger from afar”—is thought to measure around 800 by 100 feet and has a rare cigar-like shape. It is currently hurtling through the solar system at incredible speeds—around 16 miles per second—although it is tumbling rather than smoothly rotating.
Notice of Correction to the Specific Research Objectives for PA-16-175 Exploratory Grants in Cancer Epidemiology and Genomics Research (R21)"
Notice of Correction of Earliest Start Date for RFA-RM-18-018 Somatic Cell Genome Editing Dissemination and Coordinating Center (U24 - Clinical Trial Not Allowed)"
Two people with severe vision loss due to a degenerative eye disease are able to read after embryonic stem cell treatment, researchers said Monday. The pair suffer from "wet" age-related macular degeneration, which can blur vision or cause a blind spot when abnormal blood vessels leak fluids into the eye, causing damage to a layer of cells called the retinal pigment epithelium (RPE). For the study, a British-American research team used human embryonic stem cells (hESC) to grow RPE cells on a thin plastic scaffold.
Notice of NINR's Participation in PA-18-272 Targeted basic behavioral and social science and intervention development for HIV prevention and care (R21 Clinical Trial Optional)
Notice of Change in Eligibility of Foreign Components and Revision of Award Budget for PAR-18-103 "Limited Competition: Small Grant Program for NIDDK K01/K08/K23 Recipients (R03 Clinical Trial Optional)"
Notice of NINR's Participation in PA-18-273 Targeted basic behavioral and social science and intervention development for HIV prevention and care (R01 Clinical Trial Optional)
Notice of NIMH Participation in PA-18-488 "NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)"
Notice of NINR's Participation in PA-18-271 Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R21 Clinical Trial Optional)
Notice of Technical Assistance Webinar for RFA-HL-19-014: Stimulating T4 Implementation Research to Optimize Integration of Proven-effective Interventions for Heart, Lung, and Blood Diseases and Sleep Disorders into Practice (STIMULATE)
Notice to Clarify the Types of Clinical Trials NIBIB Will Support Under PA-18-048 Zika Virus (ZIKV) Complications (R21 Clinical Trial Optional)
A former Cambridge Analytica employee claims the company harvested information from 50 million Facebook users. The company, best known for its work on Donald Trump's 2016 presidential campaign used the data to build psychological profiles so voters could be targeted with ads and stories.
Mathematical physicist and cosmologist Stephen Hawking was best known for his work exploring the relationship between black holes and quantum physics. Black holes loom large in the popular imagination—schoolchildren ponder why the whole universe doesn’t collapse into one. Why do black holes exist?
Notice of NCI's Participation on PA-18-498, End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness (R01 Clinical Trial Optional)
Notice of NCI's participation on PA-18-499, End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness (R21 Clinical Trial Optional)
Black holes are voracious eaters, but they don't have the nicest table manners. As they rip into a star, they tend to produce a bright flash of light that astronomers call a tidal disruption flare, the celestial equivalent of all the applesauce that fails to quite make it down a baby's throat. “This is the first time we’ve seen a jet that’s controlled by a feeding supermassive black hole,” co-author Dheeraj Pasham, an astronomer at MIT, said in a press release.
Notice of NINR's Participation in PA-18-281 Strengthening the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum through Behavioral, Social, and Implementation Science (R01 Clinical Trial Optional)
NINDS Notice to Clarify the Types of Clinical Trial Applications NINDS Will Support Under PA-18-159 "Mechanisms, Models, Measurement, and Management in Pain Research (R21 - Clinical Trial Optional)"
NIH Funding Opportunities
- Computational fluid dynamics (CFD) and discrete element modeling (DEM) approach for predictions of dry powder inhaler (DPI) drug delivery
- Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)
- International Bioethics Research Training Program (D43 Clinical Trial Optional)
- Three-Dimensional Approach for Modeling Nasal Mucociliary Clearance via Computational Fluid Dynamics (CFD)
- Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems